Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Development and characterization of an in vitro system of the human retina using cultured cell lines.

Churm R, Dunseath GJ, Prior SL, Thomas RL, Banerjee S, Owens DR.

Clin Exp Ophthalmol. 2019 Jun 29. doi: 10.1111/ceo.13578. [Epub ahead of print]

PMID:
31254428
2.

Detecting autoreactive B cells in the peripheral blood of people with type 1 diabetes using ELISpot.

Powell WE, Hanna SJ, Hocter CN, Robinson E, Lewis M, Dunseath G, Luzio S, Howell A, Dayan CM, Wong FS.

J Immunol Methods. 2019 Aug;471:61-65. doi: 10.1016/j.jim.2019.05.007. Epub 2019 May 29.

PMID:
31152768
3.

Performance evaluation of a self-administered home oral glucose tolerance test kit in a controlled clinical research setting.

Dunseath GJ, Bright D, Jones C, Dowrick S, Cheung WY, Luzio SD.

Diabet Med. 2019 Jul;36(7):862-867. doi: 10.1111/dme.13961. Epub 2019 Apr 26.

PMID:
30972793
4.

Comparative Accuracy Evaluation of a Blood Glucose Meter With Novel Hematocrit Correction Technology, With Three Currently Used Commercially Available Blood Glucose Monitoring Systems.

Dunseath GJ, Bright D, Luzio SD.

J Diabetes Sci Technol. 2019 May;13(3):568-574. doi: 10.1177/1932296818821389. Epub 2019 Jan 9.

PMID:
30623673
5.

Proinsulin in the identification and risk stratification of gestational diabetes mellitus: study protocol for a prospective, longitudinal cohort study.

Peter R, Bright D, Cheung WY, Luzio SD, Dunseath GJ.

BMJ Open. 2018 Aug 29;8(8):e022571. doi: 10.1136/bmjopen-2018-022571.

6.

Loss of CXCR3 expression on memory B cells in individuals with long-standing type 1 diabetes.

Powell WE, Hanna SJ, Hocter CN, Robinson E, Davies J, Dunseath GJ, Luzio S, Farewell D, Wen L, Dayan CM, Price DA, Ladell K, Wong FS.

Diabetologia. 2018 Aug;61(8):1794-1803. doi: 10.1007/s00125-018-4651-x. Epub 2018 Jun 7.

7.

Microsampling Collection Methods for Measurement of C-peptide in Whole Blood.

Jones C, Dunseath GJ, Lemon J, Luzio SD.

J Diabetes Sci Technol. 2018 Sep;12(5):1024-1028. doi: 10.1177/1932296818763464. Epub 2018 Mar 9.

8.

Stability of proinsulin in whole blood.

Bright DJ, Dunseath GJ, Peter R, Luzio S.

Clin Biochem. 2018 Feb;52:153-155. doi: 10.1016/j.clinbiochem.2017.10.005. Epub 2017 Oct 16.

PMID:
29051035
9.

Comparison of a point-of-care analyser for the determination of HbA1c with HPLC method.

Grant DA, Dunseath GJ, Churm R, Luzio SD.

Pract Lab Med. 2017 Apr 4;8:26-29. doi: 10.1016/j.plabm.2017.04.001. eCollection 2017 Aug.

10.

Metabolic and immune effects of immunotherapy with proinsulin peptide in human new-onset type 1 diabetes.

Alhadj Ali M, Liu YF, Arif S, Tatovic D, Shariff H, Gibson VB, Yusuf N, Baptista R, Eichmann M, Petrov N, Heck S, Yang JHM, Tree TIM, Pujol-Autonell I, Yeo L, Baumard LR, Stenson R, Howell A, Clark A, Boult Z, Powrie J, Adams L, Wong FS, Luzio S, Dunseath G, Green K, O'Keefe A, Bayly G, Thorogood N, Andrews R, Leech N, Joseph F, Nair S, Seal S, Cheung H, Beam C, Hills R, Peakman M, Dayan CM.

Sci Transl Med. 2017 Aug 9;9(402). pii: eaaf7779. doi: 10.1126/scitranslmed.aaf7779.

PMID:
28794283
11.

Accuracy Evaluation of a Blood Glucose Monitoring System According to EN ISO 15197:2015.

Bright D, Dunseath G, Berti F, Scuffi C, Valgimigli F, Luzio S.

J Diabetes Sci Technol. 2017 Jul;11(4):849-850. doi: 10.1177/1932296817695340. Epub 2017 Feb 1. No abstract available.

12.

Stimulated urine C-peptide creatinine ratio vs serum C-peptide level for monitoring of β-cell function in the first year after diagnosis of Type 1 diabetes.

Tatovic D, Luzio S, Dunseath G, Liu Y, Alhadj Ali M, Peakman M, Dayan CM; MonoPepT1De Study Group.

Diabet Med. 2016 Nov;33(11):1564-1568. doi: 10.1111/dme.13186. Epub 2016 Aug 8.

PMID:
27425010
13.

Postmarket Approval Surveillance of a Low Acquisition Cost Blood Glucose Monitoring System: Assessment of the Accuracy Following ISO 15197:2013.

Grant DA, Dunseath GJ, Bain SC, Luzio S.

J Diabetes Sci Technol. 2016 Aug 22;10(5):1195-6. doi: 10.1177/1932296816648991. Print 2016 Sep. No abstract available.

14.

Diabetic Retinopathy in Newly Diagnosed Subjects With Type 2 Diabetes Mellitus: Contribution of β-Cell Function.

Roy Chowdhury S, Thomas RL, Dunseath GJ, Peter R, Rees DA, North RV, Luzio SD, Owens DR.

J Clin Endocrinol Metab. 2016 Feb;101(2):572-80. doi: 10.1210/jc.2015-2203. Epub 2015 Dec 11.

PMID:
26652932
15.

Association between the preoperative fasting and postprandial C-peptide AUC with resolution of type 2 diabetes 6 months following bariatric surgery.

Mallipedhi A, Min T, Prior SL, MacIver C, Luzio SD, Dunseath G, Bracken RM, Islam S, Barry JD, Caplin S, Stephens JW.

Metabolism. 2015 Nov;64(11):1556-63. doi: 10.1016/j.metabol.2015.08.009. Epub 2015 Aug 18.

PMID:
26386694
16.

Bridging-type enzyme-linked immunoassay for zinc transporter 8 autoantibody measurements in adult patients with diabetes mellitus.

Dunseath G, Ananieva-Jordanova R, Coles R, Powell M, Amoroso M, Furmaniak J, Smith BR, Dayan C, Luzio S.

Clin Chim Acta. 2015 Jul 20;447:90-5. doi: 10.1016/j.cca.2015.05.010. Epub 2015 May 22.

PMID:
26006309
17.

Similar magnitude of post-exercise hyperglycemia despite manipulating resistance exercise intensity in type 1 diabetes individuals.

Turner D, Gray BJ, Luzio S, Dunseath G, Bain SC, Hanley S, Richards A, Rhydderch DC, Ayles M, Kilduff LP, Campbell MD, West DJ, Bracken RM.

Scand J Med Sci Sports. 2016 Apr;26(4):404-12. doi: 10.1111/sms.12472. Epub 2015 Apr 28.

PMID:
25919405
18.

Changes in plasma levels of N-arachidonoyl ethanolamine and N-palmitoylethanolamine following bariatric surgery in morbidly obese females with impaired glucose homeostasis.

Mallipedhi A, Prior SL, Dunseath G, Bracken RM, Barry J, Caplin S, Eyre N, Morgan J, Baxter JN, O'Sullivan SE, Sarmad S, Barrett DA, Bain SC, Luzio SD, Stephens JW.

J Diabetes Res. 2015;2015:680867. doi: 10.1155/2015/680867. Epub 2015 Mar 22.

19.

Central arterial stiffness and diastolic dysfunction are associated with insulin resistance and abdominal obesity in young women but polycystic ovary syndrome does not confer additional risk.

Rees E, Coulson R, Dunstan F, Evans WD, Blundell HL, Luzio SD, Dunseath G, Halcox JP, Fraser AG, Rees DA.

Hum Reprod. 2014 Sep;29(9):2041-9. doi: 10.1093/humrep/deu180. Epub 2014 Jul 17.

PMID:
25035436
20.

Comparison of IFCC-calibrated HbA(1c) from laboratory and point of care testing systems.

Manley SE, Hikin LJ, Round RA, Manning PW, Luzio SD, Dunseath GJ, Nightingale PG, Stratton IM, Cramb R, Sikaris KA, Gough SC, Webber J.

Diabetes Res Clin Pract. 2014 Sep;105(3):364-72. doi: 10.1016/j.diabres.2014.05.003. Epub 2014 May 23.

PMID:
24985893
21.

Metabolic implications when employing heavy pre- and post-exercise rapid-acting insulin reductions to prevent hypoglycaemia in type 1 diabetes patients: a randomised clinical trial.

Campbell MD, Walker M, Trenell MI, Luzio S, Dunseath G, Tuner D, Bracken RM, Bain SC, Russell M, Stevenson EJ, West DJ.

PLoS One. 2014 May 23;9(5):e97143. doi: 10.1371/journal.pone.0097143. eCollection 2014.

22.

Reductions in resistance exercise-induced hyperglycaemic episodes are associated with circulating interleukin-6 in type 1 diabetes.

Turner D, Luzio S, Kilduff LP, Gray BJ, Dunseath G, Bain SC, Campbell MD, West DJ, Bracken RM.

Diabet Med. 2014 Aug;31(8):1009-13. doi: 10.1111/dme.12462. Epub 2014 Apr 25.

PMID:
24702172
23.

Impact of single and multiple sets of resistance exercise in type 1 diabetes.

Turner D, Luzio S, Gray BJ, Dunseath G, Rees ED, Kilduff LP, Campbell MD, West DJ, Bain SC, Bracken RM.

Scand J Med Sci Sports. 2015 Feb;25(1):e99-109. doi: 10.1111/sms.12202. Epub 2014 Mar 20.

PMID:
24646137
24.

A comparison of the pharmacodynamic profiles of insulin detemir and insulin glargine: a single dose clamp study in people with type 2 diabetes.

Luzio SD, Dunseath GJ, Atkinson MD, Owens DR.

Diabetes Metab. 2013 Dec;39(6):537-42. doi: 10.1016/j.diabet.2013.09.002. Epub 2013 Oct 17.

PMID:
24139704
25.

Estimates of the relative and absolute diurnal contributions of fasting and post-prandial plasma glucose over a range of hyperglycaemia in type 2 diabetes.

Peter R, Dunseath G, Luzio SD, Owens DR.

Diabetes Metab. 2013 Sep;39(4):337-42. doi: 10.1016/j.diabet.2013.07.001. Epub 2013 Aug 30.

PMID:
23993831
26.

Effects of short-term therapy with glibenclamide and repaglinide on incretin hormones and oxidative damage associated with postprandial hyperglycaemia in people with type 2 diabetes mellitus.

Stephens JW, Bodvarsdottir TB, Wareham K, Prior SL, Bracken RM, Lowe GD, Rumley A, Dunseath G, Luzio S, Deacon CF, Holst JJ, Bain SC.

Diabetes Res Clin Pract. 2011 Nov;94(2):199-206. doi: 10.1016/j.diabres.2011.07.014. Epub 2011 Aug 10.

PMID:
21835486
27.

Experience of the introduction of routine antibody testing in primary care and of running a trial for latent autoimmune diabetes in adults (LADA).

Brophy S, Davies H, Dunseath G, Stephens JW, Platts J, Lane H, Beaverstock C, Wakeman L, Russell I, Williams M, Williams DR.

Diabetes Res Clin Pract. 2011 Jul;93(1):e49-52. doi: 10.1016/j.diabres.2011.04.004. Epub 2011 May 6.

PMID:
21529979
28.

The effect of a supported exercise programme in patients with newly diagnosed Type 2 diabetes: a pilot study.

Backx K, McCann A, Wasley D, Dunseath G, Luzio S, Owens D.

J Sports Sci. 2011 Mar;29(6):579-86. doi: 10.1080/02640414.2010.544666.

PMID:
21347968
29.

Daytime variability of postprandial glucose tolerance and pancreatic B-cell function using 12-h profiles in persons with Type 2 diabetes.

Peter R, Dunseath G, Luzio SD, Chudleigh R, Roy Choudhury S, Owens DR.

Diabet Med. 2010 Mar;27(3):266-73. doi: 10.1111/j.1464-5491.2010.02949.x.

PMID:
20536488
30.

Impending hyperglycemia in normoglycemic renal transplant recipients--an experimental predictive surrogate.

Sharif A, Ravindran VK, Dunseath G, Luzio SD, Owens DR, Baboolal K.

Transplantation. 2010 Jun 15;89(11):1341-6. doi: 10.1097/TP.0b013e3181d9e1d8.

PMID:
20354482
31.

Comparison of rival metabolic syndrome classifications against pathophysiological markers in renal transplant recipients.

Sharif A, Ravindran V, Dunseath G, Luzio S, Owens DR, Baboolal K.

Transplantation. 2010 Feb 15;89(3):347-52. doi: 10.1097/TP.0b013e3181bd06d2.

PMID:
20145527
32.

Insulin resistance indexes in renal transplant recipients maintained on tacrolimus immunosuppression.

Sharif A, Ravindran V, Moore RH, Dunseath G, Luzio S, Owens DR, Baboolal K.

Transplantation. 2010 Feb 15;89(3):327-33. doi: 10.1097/TP.0b013e3181bbf2c4.

PMID:
20145524
33.

Metformin reduces arterial stiffness and improves endothelial function in young women with polycystic ovary syndrome: a randomized, placebo-controlled, crossover trial.

Agarwal N, Rice SP, Bolusani H, Luzio SD, Dunseath G, Ludgate M, Rees DA.

J Clin Endocrinol Metab. 2010 Feb;95(2):722-30. doi: 10.1210/jc.2009-1985. Epub 2009 Dec 8.

PMID:
19996308
34.

Relative and absolute contributions of postprandial and fasting plasma glucose to daytime hyperglycaemia and HbA(1c) in subjects with Type 2 diabetes.

Peter R, Dunseath G, Luzio SD, Chudleigh R, Choudhury SR, Owens DR.

Diabet Med. 2009 Oct;26(10):974-80. doi: 10.1111/j.1464-5491.2009.02809.x.

PMID:
19900228
35.

The glucose lowering effect of an oral insulin (Capsulin) during an isoglycaemic clamp study in persons with type 2 diabetes.

Luzio SD, Dunseath G, Lockett A, Broke-Smith TP, New RR, Owens DR.

Diabetes Obes Metab. 2010 Jan;12(1):82-7. doi: 10.1111/j.1463-1326.2009.01146.x. Epub 2009 Sep 25.

PMID:
19788433
36.

GADA testing: the current state of knowledge.

Davies H, Brophy S, Bain SC, Stephens JW, Lewis J, Luzio S, Dunseath G, Beaverstock C, Williams DR.

Prim Care Diabetes. 2009 Aug;3(3):189-91. doi: 10.1016/j.pcd.2009.07.002. Epub 2009 Aug 27. Review.

PMID:
19716357
37.

Complex interplay between insulinemia, glycemia, and glomerular filtration rate in nondiabetic renal transplant recipients.

Sharif A, Ravindran V, Moore RH, Baboolal K, Dunseath G, Luzio S, Owens DR.

Transplantation. 2009 Jul 27;88(2):290-2. doi: 10.1097/TP.0b013e3181acc901. No abstract available.

PMID:
19623029
38.

Insulin hyposecretion in nondiabetic, tacrolimus-treated renal transplant recipients more than 6 months posttransplantation.

Ravindran VK, Moore RH, Dunseath G, Luzio SD, Owens DR, Baboolal K.

Transplantation. 2009 Jun 27;87(12):1870-6. doi: 10.1097/TP.0b013e3181a767b3.

PMID:
19543067
39.

The effect of rosuvastatin on insulin sensitivity and pancreatic beta-cell function in nondiabetic renal transplant recipients.

Sharif A, Ravindran V, Moore R, Dunseath G, Luzio S, Owens D, Baboolal K.

Am J Transplant. 2009 Jun;9(6):1439-45. doi: 10.1111/j.1600-6143.2009.02644.x. Epub 2009 May 13.

40.

Use of cystatin C-based estimations of glomerular filtration rate in patients with type 2 diabetes.

Chudleigh RA, Ollerton RL, Dunseath G, Peter R, Harvey JN, Luzio S, Owens DR.

Diabetologia. 2009 Jul;52(7):1274-8. doi: 10.1007/s00125-009-1379-7. Epub 2009 May 9.

PMID:
19430759
41.

Performance of the revised '175' Modification of Diet in Renal Disease equation in patients with type 2 diabetes.

Chudleigh RA, Ollerton RL, Dunseath G, Peter R, Harvey JN, Luzio S, Owens DR.

Diabetologia. 2008 Sep;51(9):1714-8. doi: 10.1007/s00125-008-1086-9. Epub 2008 Jul 17.

PMID:
18633593
42.

A comparison of preprandial insulin glulisine versus insulin lispro in people with Type 2 diabetes over a 12-h period.

Luzio S, Peter R, Dunseath GJ, Mustafa L, Owens DR.

Diabetes Res Clin Pract. 2008 Feb;79(2):269-75. doi: 10.1016/j.diabres.2007.11.013. Epub 2007 Dec 27.

PMID:
18164094
43.

Influence of body weight on the performance of glomerular filtration rate estimators in subjects with type 2 diabetes.

Chudleigh RA, Dunseath G, Peter R, Harvey JN, Ollerton RL, Luzio S, Owens DR.

Diabetes Care. 2008 Jan;31(1):47-9. Epub 2007 Oct 12. No abstract available.

PMID:
17934154
44.

Insulin resistance and inflammation - A further systemic complication of COPD.

Bolton CE, Evans M, Ionescu AA, Edwards SM, Morris RH, Dunseath G, Luzio SD, Owens DR, Shale DJ.

COPD. 2007 Jun;4(2):121-6.

PMID:
17530505
45.

How reliable is estimation of glomerular filtration rate at diagnosis of type 2 diabetes?

Chudleigh RA, Dunseath G, Evans W, Harvey JN, Evans P, Ollerton R, Owens DR.

Diabetes Care. 2007 Feb;30(2):300-5.

PMID:
17259498
46.

The loss of postprandial glycemic control precedes stepwise deterioration of fasting with worsening diabetes.

Monnier L, Colette C, Dunseath GJ, Owens DR.

Diabetes Care. 2007 Feb;30(2):263-9.

PMID:
17259492
47.
48.

Comparison of the pharmacokinetics and pharmacodynamics of biphasic insulin aspart and insulin glargine in people with type 2 diabetes.

Luzio S, Dunseath G, Peter R, Pauvaday V, Owens DR.

Diabetologia. 2006 Jun;49(6):1163-8. Epub 2006 Apr 5.

PMID:
16596358
49.

The systemic inflammatory response to exercise in adults with cystic fibrosis.

Ionescu AA, Mickleborough TD, Bolton CE, Lindley MR, Nixon LS, Dunseath G, Luzio S, Owens DR, Shale DJ.

J Cyst Fibros. 2006 May;5(2):105-12. Epub 2006 Jan 3.

50.

Beta-cell response during a meal test: a comparative study of incremental doses of repaglinide in type 2 diabetic patients.

Cozma LS, Luzio SD, Dunseath GJ, Underwood PM, Owens DR.

Diabetes Care. 2005 May;28(5):1001-7.

PMID:
15855557

Supplemental Content

Loading ...
Support Center